AJANTPHARM: Strong FY26 growth in revenue, profit, and margins, with India and US generics leading
AJANTPHARM: Strong FY26 growth in revenue, profit, and margins, with India and US generics leading
AJANTPHARM: Strong FY26 growth in revenue, profit, and margins, with India and US generics leading
Sector
BROAD_MARKET
News Type
MARKET
Impact Level
HIGH
AI Sentiment
POSITIVE
Published
09 May 2026
📎 Sources
Quartr | https://www.tradingview.com/news/urn:summary_document_report:quartr.com:3284366:0-ajantpharm-strong-fy26-growth-in-revenue-profit-and-margins-with-india-and-us-generics-leading/